BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28470733)

  • 21. Diagnostic accuracy of 123 I-FP-CIT SPECT in diagnosing drug-induced parkinsonism: a prospective study.
    Olivares Romero J; Arjona Padillo A
    Neurologia; 2013 Jun; 28(5):276-82. PubMed ID: 22795922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
    Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
    J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Ishikawa T; Dhawan V; Kazumata K; Chaly T; Mandel F; Neumeyer J; Margouleff C; Babchyck B; Zanzi I; Eidelberg D
    J Nucl Med; 1996 Nov; 37(11):1760-5. PubMed ID: 8917170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
    Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
    Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT.
    Marshall VL; Reininger CB; Marquardt M; Patterson J; Hadley DM; Oertel WH; Benamer HT; Kemp P; Burn D; Tolosa E; Kulisevsky J; Cunha L; Costa D; Booij J; Tatsch K; Chaudhuri KR; Ulm G; Pogarell O; Höffken H; Gerstner A; Grosset DG
    Mov Disord; 2009 Mar; 24(4):500-8. PubMed ID: 19117369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
    Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C
    Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.
    Vlaar AM; de Nijs T; Kessels AG; Vreeling FW; Winogrodzka A; Mess WH; Tromp SC; van Kroonenburgh MJ; Weber WE
    Eur Neurol; 2008; 59(5):258-66. PubMed ID: 18264015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostic accuracy of FP-CIT SPECT in patients with parkinsonism].
    Ortega Lozano SJ; Martínez Del Valle Torres MD; Jiménez-Hoyuela García JM; Gutiérrez Cardo AL; Campos Arillo V
    Rev Esp Med Nucl; 2007; 26(5):277-85. PubMed ID: 17910836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
    Song IU; Chung YA; Oh JK; Chung SW
    Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study.
    Rossi C; Frosini D; Volterrani D; De Feo P; Unti E; Nicoletti V; Kiferle L; Bonuccelli U; Ceravolo R
    Eur J Neurol; 2010 Apr; 17(4):626-30. PubMed ID: 20050904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias.
    Brigo F; Turri G; Tinazzi M
    J Neurol Sci; 2015 Dec; 359(1-2):161-71. PubMed ID: 26671107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys.
    Booij J; Andringa G; Rijks LJ; Vermeulen RJ; De Bruin K; Boer GJ; Janssen AG; Van Royen EA
    Synapse; 1997 Nov; 27(3):183-90. PubMed ID: 9329154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease.
    Zijlmans J; Evans A; Fontes F; Katzenschlager R; Gacinovic S; Lees AJ; Costa D
    Mov Disord; 2007 Jul; 22(9):1278-85. PubMed ID: 17486613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems.
    Meyer PT; Sattler B; Lincke T; Seese A; Sabri O
    J Nucl Med; 2003 May; 44(5):839-45. PubMed ID: 12732687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of iterative reconstruction parameters with 3-dimensional resolution recovery, scatter and attenuation correction in ¹²³I-FP-CIT SPECT.
    Matsutomo N; Nagaki A; Yamao F; Sasaki M
    Ann Nucl Med; 2015 Aug; 29(7):636-42. PubMed ID: 25997807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Striatal dopamine transporter levels in patients with REM sleep behavior disorder: assessment with 123I-FP-CIT SPECT].
    Mossa EP; Niccoli Asabella A; Iuele F; Stabile Ianora AA; Giganti M; Rubini G
    Recenti Prog Med; 2012 Nov; 103(11):500-4. PubMed ID: 23096739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's disease.
    Winogrodzka A; Bergmans P; Booij J; van Royen EA; Janssen AG; Wolters EC
    J Neural Transm (Vienna); 2001; 108(8-9):1011-9. PubMed ID: 11716136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global scaling for semi-quantitative analysis in FP-CIT SPECT.
    Kupitz D; Apostolova I; Lange C; Ulrich G; Amthauer H; Brenner W; Buchert R
    Nuklearmedizin; 2014; 53(6):234-41. PubMed ID: 25209576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.
    Camacho V; Marquié M; Lleó A; Alvés L; Artigas C; Flotats A; Duch J; Blesa R; Gómez-Isla T; Carrió I; Estorch M
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):476-83. PubMed ID: 21150861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The phase value of putamen measured by susceptibility weighted images in Parkinson's disease and in other forms of Parkinsonism: a correlation study with F18 FP-CIT PET.
    Kwon GH; Jang J; Choi HS; Hwang EJ; Jung SL; Ahn KJ; Kim BS; Yoo IeR; Kim SH; Haacke EM
    Acta Radiol; 2016 Jul; 57(7):852-60. PubMed ID: 26377263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.